What is a Ophthalmology Fractional CFO?
A fractional CFO for ophthalmology practices provides strategic financial leadership for eye care groups — covering ASC joint venture structures, LASIK vs. medical revenue strategy, and practice valuation for PE or DSO partnerships — typically engaged by ophthalmologist-owners generating $3M–$20M who are making major capital or exit decisions.
Your ASC is your most valuable asset. Do you know what it is actually worth?
Strategic financial guidance for ophthalmologist-owners managing multi-entity practices, equipment decisions, and growth opportunities.
A 4-minute test your accountant hopes you skip.
At a glance
Industry Context
The Strategic Picture for Ophthalmology Practices
Ophthalmology is one of the most attractive specialties for private equity consolidation. Retina-focused platforms (Retina Consultants of America), general ophthalmology platforms (EyeCare Partners, US Eye, Unifeye Vision Partners, Chicago Pacific Founders), and vision-integrated platforms continue aggressive roll-up activity. Multiples have ranged from 8 to 13 times EBITDA depending on subspecialty mix, ASC ownership, growth, and geography. A practice with a partially-owned ASC, strong cataract volume, and retina or oculoplastic subspecialty coverage commands a premium.
The CFO conversations in ophthalmology are unusually capital-intensive. Equipment (femtosecond lasers, phacoemulsification systems, OCT imaging, visual field equipment) involves decisions in the $100K to $800K range. Premium IOL programs require pricing strategy, patient financing, and clinical staff training. ASC expansion or acquisition decisions involve regulatory considerations (Certificate of Need in some states), capital structure, and partner economics. These are seven-figure decisions that require real modeling, not intuition.
Is This Right for You?
This service is for ophthalmology practice owners facing these challenges:
Need accurate books first? Our Accounting service for ophthalmology practices may be a better starting point.
Strategic Pitfalls
CFO-Level Mistakes We See in Ophthalmology Practices
The strategic and capital-allocation errors that cost ophthalmology practice owners the most.
01
Underinvesting in premium IOL penetration
Premium IOL conversion rates in top-quartile practices run 30 to 40 percent of cataract cases; average practices run 10 to 20 percent. Each premium conversion adds $1,500 to $3,000 of high-margin revenue. Counselor training and patient education drive this number more than physician preference.
02
Buying a femtosecond laser without volume modeling
Femtosecond lasers cost $400K to $600K plus per-click fees of $200 to $500. Without a realistic volume projection and premium IOL attach rate assumption, the laser can lose money for years. Real ROI analysis is required before purchase.
03
Not monetizing ASC ownership properly
Ophthalmologists often own ASC investor shares but do not track ASC distributions separately from clinical income. When planning an exit, the ASC interest often has significant independent value that owners have not quantified.
04
Accepting the first PE offer without subspecialty analysis
A retina practice attached to a general ophthalmology group may be individually worth more to a retina-focused consolidator than to the general platform bidder. Without understanding the subspecialty-specific buyer landscape, owners often leave 15 to 30 percent on the table.
05
Under-pricing optical shop services
Optical dispensers and retail pricing is often set based on cost-plus rather than market value. A properly positioned optical operation can achieve 65 to 75 percent gross margin and drive patient retention; one priced below market generates low margin and fails to contribute meaningfully to practice EBITDA.
The Numbers That Matter
CFO Dashboard Metrics for Ophthalmology Practices
Adjusted EBITDA
- Earnings before interest, taxes, depreciation, and amortization with owner compensation normalized.
Combined EBITDA Margin
Healthy range: 25 to 35 percent for integrated practices
- Adjusted EBITDA across practice and ASC as a percentage of combined collections.
ASC EBITDA Margin
Healthy range: 35 to 50 percent
- ASC net income plus depreciation and amortization, divided by ASC collections.
Premium IOL Revenue
- Non-covered premium lens revenue collected directly from patients.
Equipment ROI Period
Healthy range: Under 36 months for major capital
- Months to recoup equipment capital cost through incremental case revenue.
Subspecialty Mix
- Revenue by subspecialty (general, cornea, retina, glaucoma, oculoplastic) as percentage of total.
Days Cash on Hand
Healthy range: 60 to 120 days
- Cash reserves divided by average daily operating expenses.
Capital & Vendor Strategy
Equipment, Software, and Partner Decisions
Capital allocation in ophthalmology is particularly complex because decisions span the practice, the optical shop, and the ASC. Each requires different ROI modeling. A femtosecond laser affects practice and ASC economics simultaneously; an optical inventory investment affects only the optical shop; an ASC expansion involves regulatory, capital, and partner considerations.
From an M&A perspective, the subspecialty mix matters enormously. Retina practices trade at premiums because of anti-VEGF drug spread and predictable injection volume. Cataract-heavy general practices with ASC participation trade at premiums because of ASC economics. Glaucoma and medical eye practices trade at lower multiples because of lower margin profile. A CFO guides the owner through understanding which parts of their practice are most valuable to which buyers, and how to position for the most favorable transaction.
What's Included
How a Fractional CFO Works for Ophthalmology Practices
Ophthalmology-specific strategic leadership that goes beyond reporting.
ASC Strategy & Valuation
- •ASC ownership share valuation
- •Capacity expansion vs partner surgeon recruitment analysis
- •ASC syndication and management company evaluation
Capital & Equipment Planning
- •Multi-year equipment replacement and upgrade roadmap
- •Femtosecond laser ROI analysis
- •Diagnostic technology investment prioritization
- •Financing structure optimization
Growth Strategy
- •Premium service line development (premium IOLs, dry eye, cosmetic)
- •Satellite location vs referral network strategy
- •Optometrist partnership models
M&A and Exit Planning
- •Practice valuation with ophthalmology-specific multiples
- •PE platform and add-on analysis
- •Succession planning and partner transitions
Results
What Ophthalmology Practices Experience
| Metric | Typical Outcome |
|---|---|
| ASC reallocation | Correcting shared-cost allocation added several hundred thousand dollars to reported practice profit |
| Premium IOL margin | Margin roughly doubled through pricing and implant cost negotiation, adding six figures annually |
| Optical shop improvement | Margin moved into the high 20s through vendor consolidation, adding roughly $90K annually |
Illustrative Scenario
What This Looks Like In Practice
A multi-surgeon ophthalmology practice with ASC ownership, an optical shop, and employed optometrists, combined revenue in the $8M–$10M range. Owner-surgeon take-home was below expectations. Nobody could clearly explain the financial relationship between the practice, the ASC, and the optical shop.
What we typically find:
- •ASC cost allocation subsidizing practice overhead by several hundred thousand dollars a year, so the practice looked profitable only because the ASC was absorbing shared costs disproportionately
- •Premium IOL upgrades generating meaningful patient revenue but at a sub-25% margin, driven by untracked implant costs and under-priced upgrade fees
- •The optical shop running at a low-double-digit margin versus a more typical 25–35% range, with frame purchasing fragmented across multiple vendors
- •Anti-VEGF drug waste billing (JW modifier) not being submitted, leaving mid-five figures in unbilled drug waste per year
Representative results
Correcting shared-cost allocation added several hundred thousand dollars to reported practice profit
ASC reallocation
Margin roughly doubled through pricing and implant cost negotiation, adding six figures annually
Premium IOL margin
Margin moved into the high 20s through vendor consolidation, adding roughly $90K annually
Optical shop improvement
The takeaway
The pattern we see in multi-entity ophthalmology: without clean separation between practice, ASC, and optical, shared costs quietly migrate to whichever entity the GL defaults to. One entity ends up looking healthy while another absorbs the difference.
Think your ophthalmology practice has similar potential?
Common Questions About Fractional CFO for Ophthalmology Practices
Stop guessing. Start leading your ophthalmology practice with data.
Take the 4-minute financial assessment—and find out if your ophthalmology practice is ready for strategic CFO leadership.
The test your accountant hopes you skip.
By state
Ophthalmology Practices accounting and CFO support, by state
State-level tax, payer, and regulatory context shapes what “good” looks like for ophthalmology practices practices. The pages below walk through each state's specifics.